Starpharma Holdings Limited (SPL.AX)
AUD 0.1
(3.09%)
AUD 0.1
(3.09%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -19.83 Million AUD | 26.3% |
| 2023 | -26.9 Million AUD | 35.52% |
| 2022 | -41.72 Million AUD | 29.67% |
| 2021 | -59.33 Million AUD | -108.33% |
| 2020 | -28.48 Million AUD | 30.92% |
| 2019 | -41.22 Million AUD | 19.59% |
| 2018 | -51.27 Million AUD | 16.11% |
| 2017 | -61.11 Million AUD | -33.0% |
| 2016 | -45.95 Million AUD | -49.2% |
| 2015 | -30.8 Million AUD | -28.59% |
| 2014 | -23.95 Million AUD | 29.01% |
| 2013 | -33.74 Million AUD | 20.93% |
| 2012 | -42.67 Million AUD | -126.35% |
| 2011 | -18.85 Million AUD | 16.92% |
| 2010 | -22.69 Million AUD | -100.77% |
| 2009 | -11.3 Million AUD | -59.97% |
| 2008 | -7.06 Million AUD | 27.5% |
| 2007 | -9.74 Million AUD | 29.52% |
| 2006 | -13.82 Million AUD | -72.26% |
| 2005 | -8.02 Million AUD | 48.06% |
| 2004 | -15.45 Million AUD | -102.61% |
| 2003 | -7.62 Million AUD | 56.25% |
| 2002 | -17.43 Million AUD | 31.39% |
| 2001 | -25.41 Million AUD | 9.5% |
| 2000 | -28.07 Million AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -19.83 Million AUD | 0.0% |
| 2024 Q2 | -29 Million AUD | 0.0% |
| 2024 FY | -19.83 Million AUD | 26.3% |
| 2023 Q4 | -26.9 Million AUD | 0.0% |
| 2023 Q2 | -36.18 Million AUD | 0.0% |
| 2023 FY | -26.9 Million AUD | 35.52% |
| 2022 Q4 | -41.72 Million AUD | 0.0% |
| 2022 Q2 | -47.54 Million AUD | 0.0% |
| 2022 FY | -41.72 Million AUD | 29.67% |
| 2021 Q4 | -59.33 Million AUD | 0.0% |
| 2021 FY | -59.33 Million AUD | -108.33% |
| 2021 Q2 | -68.77 Million AUD | 0.0% |
| 2020 FY | -28.48 Million AUD | 30.92% |
| 2020 Q2 | -34 Million AUD | 0.0% |
| 2020 Q4 | -28.48 Million AUD | 0.0% |
| 2019 Q2 | -44.39 Million AUD | 0.0% |
| 2019 Q4 | -41.22 Million AUD | 0.0% |
| 2019 FY | -41.22 Million AUD | 19.59% |
| 2018 Q2 | -49.86 Million AUD | 0.0% |
| 2018 Q4 | -51.27 Million AUD | 0.0% |
| 2018 FY | -51.27 Million AUD | 16.11% |
| 2017 FY | -61.11 Million AUD | -33.0% |
| 2017 Q4 | -61.11 Million AUD | 0.0% |
| 2017 Q2 | -36.28 Million AUD | 0.0% |
| 2016 Q4 | -45.95 Million AUD | 0.0% |
| 2016 Q2 | -54.68 Million AUD | 0.0% |
| 2016 FY | -45.95 Million AUD | -49.2% |
| 2015 FY | -30.8 Million AUD | -28.59% |
| 2015 Q4 | -30.8 Million AUD | 0.0% |
| 2015 Q2 | -39.28 Million AUD | 0.0% |
| 2014 FY | -23.95 Million AUD | 29.01% |
| 2014 Q2 | -27.77 Million AUD | 0.0% |
| 2014 Q4 | -23.95 Million AUD | 0.0% |
| 2013 Q2 | -33.18 Million AUD | 0.0% |
| 2013 Q4 | -33.74 Million AUD | 0.3% |
| 2013 FY | -33.74 Million AUD | 20.93% |
| 2013 Q1 | -33.18 Million AUD | 22.24% |
| 2013 Q3 | -33.84 Million AUD | -1.98% |
| 2012 FY | -42.67 Million AUD | -126.35% |
| 2012 Q4 | -42.67 Million AUD | 0.0% |
| 2011 Q4 | -18.85 Million AUD | 0.0% |
| 2011 FY | -18.85 Million AUD | 16.92% |
| 2010 FY | -22.69 Million AUD | -100.77% |
| 2010 Q4 | -22.69 Million AUD | 0.0% |
| 2009 FY | -11.3 Million AUD | -59.97% |
| 2009 Q4 | -11.3 Million AUD | 0.0% |
| 2008 FY | -7.06 Million AUD | 27.5% |
| 2008 Q4 | -7.06 Million AUD | 0.0% |
| 2007 Q4 | -9.74 Million AUD | 0.0% |
| 2007 FY | -9.74 Million AUD | 29.52% |
| 2006 FY | -13.82 Million AUD | -72.26% |
| 2006 Q4 | -13.82 Million AUD | 0.0% |
| 2005 FY | -8.02 Million AUD | 48.06% |
| 2005 Q4 | -8.02 Million AUD | 0.0% |
| 2004 Q4 | -15.45 Million AUD | 0.0% |
| 2004 FY | -15.45 Million AUD | -102.61% |
| 2003 Q4 | -7.62 Million AUD | 0.0% |
| 2003 FY | -7.62 Million AUD | 56.25% |
| 2002 FY | -17.43 Million AUD | 31.39% |
| 2002 Q4 | -17.43 Million AUD | 0.0% |
| 2001 Q4 | -25.41 Million AUD | 0.0% |
| 2001 FY | -25.41 Million AUD | 9.5% |
| 2000 FY | -28.07 Million AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -4.938% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1919.332% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 491.37% |
| Biome Australia Limited | -1.56 Million AUD | -1168.999% |
| Patrys Limited | -2.24 Million AUD | -785.096% |
| Orthocell Limited | -19.92 Million AUD | 0.465% |
| Imugene Limited | -91.56 Million AUD | 78.34% |
| Noxopharm Limited | -2.31 Million AUD | -754.854% |
| PYC Therapeutics Limited | -65.76 Million AUD | 69.843% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -549.59% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -95.145% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -213.606% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -219.592% |
| CSL Limited | 15.76 Billion AUD | 100.126% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -55.981% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2694.979% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 89.162% |
| Nanollose Limited | -96.22 Thousand AUD | -20510.029% |
| Memphasys Limited | 4.13 Million AUD | 579.57% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -229.158% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -300.311% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -987.525% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 74.994% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1501.41% |
| Race Oncology Limited | -17.18 Million AUD | -15.377% |
| Nyrada Inc. | -4.76 Million AUD | -315.82% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 81.254% |
| Dimerix Limited | -21.99 Million AUD | 9.821% |
| PharmAust Limited | -9.71 Million AUD | -104.157% |
| Immutep Limited | -122.18 Million AUD | 83.769% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 85.472% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -58.912% |
| BTC Health Limited | -2.02 Million AUD | -880.736% |
| Acrux Limited | -1.45 Million AUD | -1260.219% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -16.017% |
| Biotron Limited | -386.06 Thousand AUD | -5036.919% |
| Tissue Repair Ltd | -16.44 Million AUD | -20.625% |
| AdAlta Limited | -845.17 Thousand AUD | -2246.502% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -6.767% |
| Hexima Limited | -2.22 Million AUD | -790.84% |
| AnteoTech Limited | -5 Million AUD | -296.519% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -12.8% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -483.958% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -272.135% |
| Actinogen Medical Limited | -9.13 Million AUD | -117.178% |
| Immuron Limited | -11.48 Million AUD | -72.695% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -24.63% |